/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
0
0
David Anderson
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
David Anderson2022-10-19 16:48:382022-10-19 16:57:26Peptilogics to Present Data at IDWeek 2022 on PLG0206, an Engineered Antimicrobial Peptide Targeting Bacteria Causing Periprosthetic Joint Infection
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
0
0
David Anderson
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
David Anderson2022-10-06 16:53:592022-10-06 16:57:40Peptilogics Presents Data Demonstrating Antimicrobial Activity Against Difficult to Treat Bacterial Pathogens of Engineered Peptide PLG0206 at the 2022 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
0
0
David Anderson
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
David Anderson2022-10-05 13:25:452022-10-06 16:56:54Peptilogics Announces First Patient Dosed in Phase 1b Study of PLG0206 for Periprosthetic Joint Infection
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
0
0
David Anderson
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
David Anderson2022-08-15 00:00:212022-09-26 12:51:38Epiaxis Therapeutics & Peptilogics Enter Strategic Drug Discovery Partnership
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
0
0
eallison
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
eallison2022-08-09 17:32:442022-08-09 17:46:13Peptilogics Strengthens Leadership Team with Executive Appointments
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
0
0
David Anderson
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
David Anderson2022-08-05 12:17:242022-08-05 12:20:26Peptilogics to Participate in Musculoskeletal Infection Society (MSIS) 32nd Annual Open Scientific Meeting in Pittsburgh
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
0
0
David Anderson
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
David Anderson2022-07-19 05:36:532022-07-19 05:45:09Peptilogics Receives FDA Fast Track Designation for PLG0206, an Investigational Peptide Therapeutic in Development for the Treatment of Periprosthetic Joint Infection
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
0
0
eallison
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
eallison2022-07-11 20:54:252022-07-11 21:25:58Orion Biotechnology and Peptilogics Enter Strategic Research Collaboration to Enable AI-Driven Drug Discovery Against Undrugged GPCR Target
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
0
0
David Anderson
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
David Anderson2022-04-19 15:14:122022-07-28 15:16:13Peptilogics to Present Data Highlighting Designed Antimicrobial Peptide for the Treatment of Periprosthetic Joint Infection (PJI) at ECCMID 2022
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
0
0
David Anderson
/wp-content/uploads/peptilogics_inline_ko_rgb_72-300x79.png
David Anderson2022-03-22 08:00:412022-04-27 12:48:45Peptilogics’ Presentations at American Academy of Orthopedic Surgeons (AAOS) 2022 Annual Meeting Highlight Peptide Therapeutic PLG0206 for the Treatment of Periprosthetic Joint Infection (PJI)
Scroll to top
